Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Receptor-transporting protein (RTP) family members play divergent roles in the functional expression of odorant receptors.

Yu T, Su X, Pan Y, Zhuang H.

PLoS One. 2017 Jun 6;12(6):e0179067. doi: 10.1371/journal.pone.0179067. eCollection 2017.

2.

Molecular Pharmacology of δ-Opioid Receptors.

Gendron L, Cahill CM, von Zastrow M, Schiller PW, Pineyro G.

Pharmacol Rev. 2016 Jul;68(3):631-700. doi: 10.1124/pr.114.008979. Review.

3.

G Protein-Coupled Receptor Heteromers.

Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA.

Annu Rev Pharmacol Toxicol. 2016;56:403-25. doi: 10.1146/annurev-pharmtox-011613-135952. Epub 2015 Oct 22. Review.

4.

Adrenocorticotropic Hormone (ACTH) Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane.

Malik S, Dolan TM, Maben ZJ, Hinkle PM.

J Biol Chem. 2015 Nov 13;290(46):27972-85. doi: 10.1074/jbc.M115.668491. Epub 2015 Sep 30.

5.
6.

Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.

Gomes I, Gupta A, Bushlin I, Devi LA.

Front Pharmacol. 2014 Dec 3;5:268. doi: 10.3389/fphar.2014.00268. eCollection 2014. Review.

7.

Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Fujita W, Gomes I, Devi LA.

Br J Pharmacol. 2014 Sep;171(18):4155-76. doi: 10.1111/bph.12798. Review.

8.

Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information.

Zhao X, Perez-Aguilar JM, Matsunaga F, Lerner M, Xi J, Selling B, Johnson AT Jr, Saven JG, Liu R.

Anesthesiology. 2014 Oct;121(4):866-75. doi: 10.1097/ALN.0000000000000308.

9.

Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.

Ong EW, Xue L, Olmstead MC, Cahill CM.

Br J Pharmacol. 2015 Jan;172(2):615-29. doi: 10.1111/bph.12761. Epub 2014 Jul 1.

10.

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors.

Ong EW, Cahill CM.

Cells. 2014 Mar 5;3(1):152-79. doi: 10.3390/cells3010152.

11.

In vivo opioid receptor heteromerization: where do we stand?

Massotte D.

Br J Pharmacol. 2015 Jan;172(2):420-34. doi: 10.1111/bph.12702. Epub 2014 Jul 1. Review.

12.

Recent advances on the δ opioid receptor: from trafficking to function.

Gendron L, Mittal N, Beaudry H, Walwyn W.

Br J Pharmacol. 2015 Jan;172(2):403-19. doi: 10.1111/bph.12706. Epub 2014 Jul 1. Review.

13.

Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Tao YX, Conn PM.

Endocr Rev. 2014 Aug;35(4):602-47. doi: 10.1210/er.2013-1121. Epub 2014 Mar 24. Review.

14.

The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Klenowski P, Morgan M, Bartlett SE.

Br J Pharmacol. 2015 Jan;172(2):297-310. doi: 10.1111/bph.12618. Epub 2014 Jul 1. Review.

15.

Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.

Fujita W, Gomes I, Devi LA.

Br J Pharmacol. 2015 Jan;172(2):375-87. doi: 10.1111/bph.12663. Epub 2014 Jul 1. Review.

16.

Opioid-induced cardioprotection.

Tanaka K, Kersten JR, Riess ML.

Curr Pharm Des. 2014;20(36):5696-705. Review.

17.

A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate.

Binda C, Génier S, Cartier A, Larrivée JF, Stankova J, Young JC, Parent JL.

J Cell Biol. 2014 Feb 3;204(3):377-93. doi: 10.1083/jcb.201304015.

18.

G protein-coupled receptors: what a difference a 'partner' makes.

Roux BT, Cottrell GS.

Int J Mol Sci. 2014 Jan 16;15(1):1112-42. doi: 10.3390/ijms15011112. Review.

19.

Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.

Podolsky AT, Sandweiss A, Hu J, Bilsky EJ, Cain JP, Kumirov VK, Lee YS, Hruby VJ, Vardanyan RS, Vanderah TW.

Life Sci. 2013 Dec 18;93(25-26):1010-6. doi: 10.1016/j.lfs.2013.09.016. Epub 2013 Sep 29.

20.

Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines.

Martinez-Fernandez A, Li X, Hartjes KA, Terzic A, Nelson TJ.

Circ Cardiovasc Genet. 2013 Oct;6(5):462-71. doi: 10.1161/CIRCGENETICS.113.000045. Epub 2013 Sep 14.

Supplemental Content

Support Center